Significance of Lipoprotein(a) in Coronary Artery Disease ― A Comparative Study of Patients Undergoing Percutaneous Coronary Intervention and Healthy Individuals ―

Read full text Summarise with VIRAT
Authors: Tomoaki Okada, Kentaro Ejiri, Toru Miyoshi, Kosuke Seiyama, J Hasegawa, Masatomo Ozaki, Masahiro Sogo, Satoko Ugawa, Kazumasa Nosaka, Masayuki Doi
Cited by: 0
References: 50

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Background: Lipoprotein(a) is a risk factor for atherosclerotic cardiovascular disease (ASCVD). However, its distribution based on coronary artery disease (CAD) in the Japanese population remains unclear. We compared lipoprotein(a) distributions among patients with acute coronary syndrome (ACS), patients with chronic coronary syndrome (CCS), and controls. Methods and Results: We analyzed 3,710 individuals who visited Kagawa Prefectural Central Hospital from April 2019 to March 2024. Patients who underwent percutaneous coronary intervention (PCI) were classified into ACS (n=724) and CCS (n=579) groups. Another 2,407 individuals without ASCVD undergoing medical check-ups were the controls. Lipoprotein(a) levels were measured before PCI or during check-up. Distributions and associations with prevalent CAD were assessed using multivariable logistic regression. The mean ages were 70, 72, and 56 years in the ACS, CCS, and control groups, respectively (P

Fields of Study & Subjects

Lipoproteins and Cardiovascular Health Atherosclerosis and Cardiovascular Diseases Diabetes Cardiovascular Risks and Lipoproteins

Publication details

Journal / source
Circulation Reports
Volume
8
Issue
6
Pages
943–951
Publication date
30 March 2026
Language
EN